✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Raymed Labs Ltd.

RAYLA

Market Cap
₹1 Cr.
P/E
0.00

Raymed Labs Ltd.

About
Raymed Labs Ltd is a pharmaceutical company that specializes in manufacturing a wide range of products including antibiotics, anti-inflammatories, analgesics, and antipyretics for both human and veter… Read more
Raymed Labs Ltd is a pharmaceutical company that specializes in manufacturing a wide range of … Read more
Low
2
52W Range
High
3
  • Raymed Labs
  • Hemo Organic
  • Zyden Gentec

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

3 No

Negative for this company

7 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Raymed Labs Ltd. Business

Raymed Labs Ltd specializes in the manufacturing of a diverse range of pharmaceutical products including antibiotics, anti-inflammatories, and other medications for both human and veterinary use.

Raymed Labs major competitors are Hemo Organic, Zyden Gentec, Fabino Enterprises, Adline Chem Lab, MPS Pharmaa, Shamrock Indl. Co, Kobo Biotech.
Market Cap of Raymed Labs is ₹1 Crs.
While the median market cap of its peers are ₹6 Crs.

Raymed Labs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice
Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material